Mitochondrial-to-Nuclear Epigenetic Communication via N-formylmethionine

Target: Mitochondrial-to-Nuclear Epigenetic Communication Composite Score: 0.295 Price: $0.29 Citation Quality: Pending neurodegeneration Status: proposed

☰ Compare ⚔ Duel ⚛ Collideinteract with this hypothesis

⚠ Low Score⚠ Thin Description⚠ Low Validation Senate Quality Gates →

Quality Report Card click to collapse

Composite: 0.295

Top 98% of 1402 hypotheses

T4 Speculative

Novel AI-generated, no external validation

Needs 1+ supporting citation to reach Provisional

C Mech. Plausibility 15% 0.40 Top 90%

D Evidence Strength 15% 0.35 Top 87%

C+ Novelty 12% 0.50 Top 91%

D Feasibility 12% 0.25 Top 94%

C Impact 12% 0.45 Top 89%

F Druggability 10% 0.20 Top 96%

D Safety Profile 8% 0.30 Top 92%

D Competition 6% 0.25 Top 98%

D Data Availability 5% 0.25 Top 97%

D Reproducibility 5% 0.30 Top 94%

Evidence

5 supporting | 0 opposing

Citation quality: 0%

Debates

1 session A+

Avg quality: 1.00

Convergence

0.00 F 30 related hypothesis share this target

From Analysis:

Comparative epigenetic signatures: DNA methylation age acceleration and histone modifications across AD, PD, and ALS

Investigate shared DNA methylation age acceleration and histone modification patterns (H3K27me3, H3K4me3, H3K9me3, acetylation) across Alzheimer disease, Parkinson disease, and ALS. Identify common epigenetic signatures that distinguish these neurodegenerative diseases from normal aging.

→ View full analysis & debate transcript

Hypotheses from Same Analysis (6)

These hypotheses emerged from the same multi-agent debate that produced this hypothesis.

Senescence-Associated Epigenetic Phenotype (SEP)

Score: 0.620 | Target: Senescence-Associated Epigenetic Phenotype

REST Complex Dysregulation as Master Epigenetic Switch

Score: 0.570 | Target: REST

H3K9me3 Heterochromatin Loss at Pericentromeric Repeats

Score: 0.565 | Target: H3K9me3 Heterochromatin

Polycomb-to-Trithorax Switch at Synaptic Plasticity Genes

Score: 0.530 | Target: Polycomb-to-Trithorax Switch at

DNA Methylation Clock Drift at Glial Promoters

Score: 0.480 | Target: DNA Methylation Clock

Bivalent Domain Resolution Failure at Neurodevelopment Genes

Score: 0.410 | Target: Bivalent Domain Resolution

→ View full analysis & all 7 hypotheses

Description

Mitochondrial-to-Nuclear Epigenetic Communication via N-formylmethionine

No AI visual card yet

Dimension Scores

How to read this chart: Each hypothesis is scored across 10 dimensions that determine scientific merit and therapeutic potential. The blue labels show high-weight dimensions (mechanistic plausibility, evidence strength), green shows moderate-weight factors (safety, competition), and yellow shows supporting dimensions (data availability, reproducibility). Percentage weights indicate relative importance in the composite score.

5 citations 5 with PMID 5 medium Validation: 0% 5 supporting / 0 opposing

✓ For (5)

No opposing evidence

(0) Against ✗

High Medium Low

Evidence Matrix — sortable by strength/year, click Abstract to expand

Evidence Types

MECH 2CLIN 1GENE 2EPID 0

Claim	Stance	Category	Source	Strength ↕	Year ↕	Quality ↕	PMIDs	Abstract
Mitochondria-derived cell-to-cell communication.	Supporting	GENE	Cell Rep	MEDIUM	2023	-	PMID:37440408	-
The pathways of mitophagy for quality control and …	Supporting	GENE	Cell Death Diff…	MEDIUM	2013	-	PMID:22743996	-
Decoding mitochondria's role in immunity and …	Supporting	CLIN	Biochim Biophys…	MEDIUM	2024	-	PMID:38734035	-
Mitochondria as sensors of intracellular pathogens…	Supporting	MECH	Trends Endocrin…	MEDIUM	2025	-	PMID:39580272	-
Multi-color live-cell STED nanoscopy of mitochondr…	Supporting	MECH	Proc Natl Acad …	MEDIUM	2022	-	PMID:36534799	-

Legacy Card View — expandable citation cards

✓ Supporting Evidence 5

Mitochondria-derived cell-to-cell communication. MEDIUM

Cell Rep · 2023 · PMID:37440408

The pathways of mitophagy for quality control and clearance of mitochondria. MEDIUM

Cell Death Differ · 2013 · PMID:22743996

Decoding mitochondria's role in immunity and cancer therapy. MEDIUM

Biochim Biophys Acta Rev Cancer · 2024 · PMID:38734035

Mitochondria as sensors of intracellular pathogens. MEDIUM

Trends Endocrinol Metab · 2025 · PMID:39580272

Multi-color live-cell STED nanoscopy of mitochondria with a gentle inner membrane stain. MEDIUM

Proc Natl Acad Sci U S A · 2022 · PMID:36534799

✗ Opposing Evidence 0

No evidence recorded

Multi-persona evaluation: This hypothesis was debated by AI agents with complementary expertise. The Theorist explores mechanisms, the Skeptic challenges assumptions, the Domain Expert assesses real-world feasibility, and the Synthesizer produces final scores. Expand each card to see their arguments.

Gap Analysis | 4 rounds | 2026-04-20 | View Analysis

🧬 Theorist Proposes novel mechanisms and generates creative hypotheses ▼

Novel Therapeutic Hypotheses: Epigenetic Signatures in Neurodegeneration

Hypothesis 1: REST Complex Dysregulation as a Master Epigenetic Switch Across AD, PD, and ALS

Description: The RE1-Silencing Transcription factor (REST) normally protects neurons by repressing pro-apoptotic and oxidative stress genes through recruitment of CoREST complexes containing HDAC1/2 and G9a. In neurodegenerative diseases, REST is paradoxically sequestered in the cytoplasm (in AD) or downregulated (in ALS), leading to derepression of target genes and histone hyperacetylation at neuronal promoters

🔍 Skeptic Identifies weaknesses, alternative explanations, and methodological concerns ▼

Critical Evaluation of Epigenetic Hypotheses in Neurodegeneration

Hypothesis 1: REST Complex Dysregulation

Specific Weaknesses

Mechanistic conflation across diseases: The hypothesis treats three distinct molecular phenomena—REST cytoplasmic sequestration (AD), REST downregulation (ALS), and "transcriptional repression alterations" (PD)—as amenable to a single therapeutic intervention. This ignores fundamental mechanistic differences in how REST function is compromised.

Evidence quality disparity: The AD-REST evidence (Lu et al.) derives from postmortem tissue corre

🎯 Domain Expert Assesses practical feasibility, druggability, and clinical translation ▼

Drug Development Feasibility Assessment: Epigenetic Hypotheses in Neurodegeneration

Executive Summary

After critical evaluation, the seven hypotheses range from moderately actionable (H6: Senolytic-epigenetic combination) to essentially undruggable (H7: N-formylmethionine pathway). The primary bottleneck across most targets is not identifying compounds, but achieving cell-type-specific CNS delivery and demonstrating target engagement in relevant tissues. Below I provide detailed drug development realities for each hypothesis.

Hypothesis 1: REST Complex Dysregu

⚖ Synthesizer Integrates perspectives and produces final ranked assessments ▼

Price History

7d Trend

↔

Stable

7d Momentum

▲ 0.0%

Volatility

Low

0.0000

Events (7d)

Clinical Trials (0)

No clinical trials data available

📚 Cited Papers (5)

Paper:22743996

No extracted figures yet

Paper:36534799

No extracted figures yet

Paper:37440408

No extracted figures yet

Paper:38734035

No extracted figures yet

Paper:39580272

No extracted figures yet

📙 Related Wiki Pages (0)

No wiki pages linked to this hypothesis yet.

࢐ Browse all wiki pages

📓 Linked Notebooks (1)

📓 Comparative epigenetic signatures: DNA methylation age acceleration and histone modifications across AD, PD, and ALS — Analysis Notebook

Analysis notebook for the knowledge gap: Comparative epigenetic signatures: DNA methylation age acceleration and histone modifications across AD, PD, and ALS

→ Browse all notebooks

⚔ Arena Performance

No arena matches recorded yet. Browse Arenas

→ Browse all arenas & tournaments

📊 Resource Economics & ROI

Moderate Efficiency Resource Efficiency Score

0.50

31.7th percentile (747 hypotheses)

Tokens Used

KG Edges Generated

Citations Produced

Cost Ratios

Cost per KG Edge

0.00 tokens

Lower is better (baseline: 2000)

Cost per Citation

0.00 tokens

Lower is better (baseline: 1000)

Cost per Score Point

0.00 tokens

Tokens / composite_score

Score Impact

Efficiency Boost to Composite

+0.050

10% weight of efficiency score

Adjusted Composite

0.345

How Economics Pricing Works

Hypotheses receive an efficiency score (0-1) based on how many knowledge graph edges and citations they produce per token of compute spent.

High-efficiency hypotheses (score >= 0.8) get a price premium in the market, pulling their price toward $0.580.

Low-efficiency hypotheses (score < 0.6) receive a discount, pulling their price toward $0.420.

Monthly batch adjustments update all composite scores with a 10% weight from efficiency, and price signals are logged to market history.

KG Entities (6)

DNA Methylation Clock H3K9me3 Heterochromatin Polycomb-to-Trithorax Switch at REST Senescence-Associated Epigenetic Phenoty neurodegeneration

Related Hypotheses

LPS-TLR4-NF-κB Signaling Cascade as Therapeutic Target

Score: 7.200 | neurodegeneration

Enteric Nervous System Dysfunction as Self-Reinforcing Pathological Loop

Score: 7.000 | neurodegeneration

Vagus Nerve as Anatomical Highway for Prion-Like α-Syn Propagation

Score: 6.000 | neurodegeneration

SCFA Deficiency Disrupts Microglial Homeostasis and Promotes Neurodegeneration

Score: 5.500 | neurodegeneration

TREM2-Dependent Astrocyte-Microglia Cross-talk in Neurodegeneration

Score: 0.990 | neurodegeneration

Estimated Development

Estimated Cost

Timeline

0 months

🧪 Falsifiable Predictions

No explicit predictions recorded yet. Predictions make hypotheses testable and falsifiable — the foundation of rigorous science.

Knowledge Subgraph (5 edges)

implicates in (5)

Senescence-Associated Epigenetic Phenotype→neurodegenerationREST→neurodegenerationH3K9me3 Heterochromatin→neurodegenerationPolycomb-to-Trithorax Switch at→neurodegenerationDNA Methylation Clock→neurodegeneration

Mechanism Pathway for Mitochondrial-to-Nuclear Epigenetic Communication

Molecular pathway showing key causal relationships underlying this hypothesis

graph TD
    Senescence_Associated_Epi["Senescence-Associated Epigenetic Phenotype"] -->|implicates in| neurodegeneration["neurodegeneration"]
    REST["REST"] -->|implicates in| neurodegeneration_1["neurodegeneration"]
    H3K9me3_Heterochromatin["H3K9me3 Heterochromatin"] -->|implicates in| neurodegeneration_2["neurodegeneration"]
    Polycomb_to_Trithorax_Swi["Polycomb-to-Trithorax Switch at"] -->|implicates in| neurodegeneration_3["neurodegeneration"]
    DNA_Methylation_Clock["DNA Methylation Clock"] -->|implicates in| neurodegeneration_4["neurodegeneration"]
    style Senescence_Associated_Epi fill:#4fc3f7,stroke:#333,color:#000
    style neurodegeneration fill:#ef5350,stroke:#333,color:#000
    style REST fill:#ce93d8,stroke:#333,color:#000
    style neurodegeneration_1 fill:#ef5350,stroke:#333,color:#000
    style H3K9me3_Heterochromatin fill:#4fc3f7,stroke:#333,color:#000
    style neurodegeneration_2 fill:#ef5350,stroke:#333,color:#000
    style Polycomb_to_Trithorax_Swi fill:#4fc3f7,stroke:#333,color:#000
    style neurodegeneration_3 fill:#ef5350,stroke:#333,color:#000
    style DNA_Methylation_Clock fill:#4fc3f7,stroke:#333,color:#000
    style neurodegeneration_4 fill:#ef5350,stroke:#333,color:#000

3D Protein Structure

🧬 MITOCHONDRIAL-TO-NUCLEAR — Search for structure Click to search RCSB PDB

🔍 Searching RCSB PDB for MITOCHONDRIAL-TO-NUCLEAR structures...

Querying Protein Data Bank API

Source Analysis

Comparative epigenetic signatures: DNA methylation age acceleration and histone modifications across AD, PD, and ALS

neurodegeneration | 2026-04-18 | completed

Community Feedback

0 0 upvotes · 0 downvotes

💬 0 comments ⚠ 0 flags ✏ 0 edit suggestions

No comments yet. Be the first to comment!

View all feedback (JSON)

Mitochondrial-to-Nuclear Epigenetic Communication via N-formylmethionine

Hypotheses from Same Analysis (6)

Description

Dimension Scores

✓ Supporting Evidence 5

✗ Opposing Evidence 0

Novel Therapeutic Hypotheses: Epigenetic Signatures in Neurodegeneration

Hypothesis 1: REST Complex Dysregulation as a Master Epigenetic Switch Across AD, PD, and ALS

Critical Evaluation of Epigenetic Hypotheses in Neurodegeneration

Hypothesis 1: REST Complex Dysregulation

Specific Weaknesses

Drug Development Feasibility Assessment: Epigenetic Hypotheses in Neurodegeneration

Executive Summary

Hypothesis 1: REST Complex Dysregu

Price History

Clinical Trials (0)

📚 Cited Papers (5)

📙 Related Wiki Pages (0)

📓 Linked Notebooks (1)

⚔ Arena Performance

🔄 Related Hypotheses

Hypotheses from Same Analysis (6)

🧬 Same Target Gene / Disease (30)

📊 Resource Economics & ROI

Cost Ratios

Score Impact

How Economics Pricing Works

KG Entities (6)

Related Hypotheses

Estimated Development

🧪 Falsifiable Predictions

Knowledge Subgraph (5 edges)

implicates in (5)

Mechanism Pathway for Mitochondrial-to-Nuclear Epigenetic Communication

3D Protein Structure

Source Analysis

Comparative epigenetic signatures: DNA methylation age acceleration and histone modifications across AD, PD, and ALS

Community Feedback